Status: current, Defined. Date: 28-Feb 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4688978017 | Product containing precisely hexylresorcinol 2.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 4688979013 | Hexylresorcinol 2.4 mg oromucosal lozenge | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Hexylresorcinol 2.4 mg oromucosal lozenge | Is a | Hexylresorcinol only product in oromucosal dose form | true | Inferred relationship | Some | ||
| Hexylresorcinol 2.4 mg oromucosal lozenge | Has manufactured dose form | Oromucosal lozenge | true | Inferred relationship | Some | ||
| Hexylresorcinol 2.4 mg oromucosal lozenge | Has unit of presentation | Lozenge | true | Inferred relationship | Some | ||
| Hexylresorcinol 2.4 mg oromucosal lozenge | Has precise active ingredient | Hexylresorcinol | true | Inferred relationship | Some | 1 | |
| Hexylresorcinol 2.4 mg oromucosal lozenge | Has BoSS | Hexylresorcinol | true | Inferred relationship | Some | 1 | |
| Hexylresorcinol 2.4 mg oromucosal lozenge | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Hexylresorcinol 2.4 mg oromucosal lozenge | Has presentation strength denominator unit | Lozenge | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR